Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 29, 2023 07:00 ET | Source: GENENTA SCIENCE SPA

The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma

MILAN, Italy and NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of...
May 16, 2023 07:00 ET | Source: GENENTA SCIENCE SPA

Genenta to Provide Update on Lead Product Temferon™

MILAN, Italy and NEW YORK, May 16, 2023 (GLOBE NEWSWIRE) -- Luigi Naldini, Ph.D., M.D., co-founder and Executive Scientific Board Chairman of Genenta Science S.p.A. (NASDAQ: GNTA), a clinical-stage...
April 26, 2023 07:00 ET | Source: GENENTA SCIENCE SPA

Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing

Funds available expected to be sufficient for Genenta to continue to operate into the first quarter of 2025Net exchange rate gain of €2.3 millionTax credit of €6.4 million MILAN,...